These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 2877852)
1. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Capell HA; Pullar T; Hunter JA Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852 [TBL] [Abstract][Full Text] [Related]
2. Leucopenia during sulphasalazine treatment for rheumatoid arthritis. Marabani M; Madhok R; Capell HA; Hunter JA Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110 [TBL] [Abstract][Full Text] [Related]
3. Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease. Laasila K; Leirisalo-Repo M Scand J Rheumatol; 1994; 23(6):338-40. PubMed ID: 7801059 [TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Ransford RA; Langman MJ Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076 [TBL] [Abstract][Full Text] [Related]
5. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment. Bliddal H; Eiberg B; Helin P; Svejgaard A Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550 [TBL] [Abstract][Full Text] [Related]
6. Sulphasalazine: a review of 40 years' experience. Watkinson G Drugs; 1986; 32 Suppl 1():1-11. PubMed ID: 2877847 [TBL] [Abstract][Full Text] [Related]
7. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy. Amos RS; Bax DE Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830 [TBL] [Abstract][Full Text] [Related]
8. Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine. Farr M; Scott DG; Bacon PA Drugs; 1986; 32 Suppl 1():49-53. PubMed ID: 2877853 [TBL] [Abstract][Full Text] [Related]
10. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis. Situnayake RD; McConkey B Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857 [No Abstract] [Full Text] [Related]
13. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium. Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471 [TBL] [Abstract][Full Text] [Related]
14. Sulfasalazine: I. An historical perspective. Bachrach WH Am J Gastroenterol; 1988 May; 83(5):487-96. PubMed ID: 2896458 [No Abstract] [Full Text] [Related]
15. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis]. Maier KP Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747 [No Abstract] [Full Text] [Related]
16. Incidence of sulphasalazine-induced male infertility. Birnie GG; McLeod TI; Watkinson G Gut; 1981 Jun; 22(6):452-5. PubMed ID: 6114898 [TBL] [Abstract][Full Text] [Related]
17. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review. Pullar T; Capell HA Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease. Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737 [TBL] [Abstract][Full Text] [Related]
19. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863 [TBL] [Abstract][Full Text] [Related]